CureVac NV (CVAC)
2.685
-0.06
(-2.19%)
USD |
NASDAQ |
Nov 14, 16:00
2.73
+0.04
(+1.68%)
After-Hours: 20:00
CureVac Total Liabilities (Quarterly): 193.27M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 193.27M |
| March 31, 2024 | 262.98M |
| December 31, 2023 | 299.90M |
| September 30, 2023 | 254.36M |
| June 30, 2023 | 272.16M |
| March 31, 2023 | 283.81M |
| December 31, 2022 | 350.91M |
| September 30, 2022 | 280.64M |
| June 30, 2022 | 316.11M |
| Date | Value |
|---|---|
| March 31, 2022 | 392.65M |
| December 31, 2021 | 531.88M |
| September 30, 2021 | 1.123B |
| June 30, 2021 | 1.149B |
| December 31, 2020 | 983.98M |
| September 30, 2020 | 305.91M |
| March 31, 2020 | 219.83M |
| December 31, 2019 | 194.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
193.27M
Minimum
Jun 2024
1.149B
Maximum
Jun 2021
436.15M
Average
299.90M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| BioNTech SE | 3.671B |
| Bayer AG | 90.05B |
| Affimed NV | 26.22M |
| InflaRx NV | 11.66M |
| Immatics NV | 256.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 596.87M |
| Shareholders Equity (Quarterly) | 403.61M |
| Current Ratio | 2.287 |